Feline immunodeficiency virus infection: An overview

Veterinary Journal

Volumn 155, Issue 2, 1998, Pages 123-137

  Hartmann, K ^a  

^a UNIVERSITY OF MUNICH   (Germany)

Author keywords

Feline acquired immunodeficiency syndrome; Feline immunodeficiency virus; FIV

Indexed keywords

ANIMAL; CARNIVORA; CAT; CAT DISEASE; FELINE IMMUNODEFICIENCY VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; ISOLATION AND PURIFICATION; PATHOPHYSIOLOGY; PHYSIOLOGY; REVIEW; VIROLOGY; VIRUS REPLICATION;

ANIMALS; CARNIVORA; CATS; FELINE ACQUIRED IMMUNODEFICIENCY SYNDROME; HIV; HUMANS; IMMUNODEFICIENCY VIRUS, FELINE; VIRUS REPLICATION;

EID: 0032020078     PISSN: 10900233     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1090-0233(98)80008-7     Document Type: Review

References (178)

1. ACKLEY, C. D., YAMAMOTO, J. K., LEVY, N., PEDERSEN, N. C. & COOPER, M. D. (1990). Immunologic abnormalities in pathogen-free cats experimentally infected with feline immunodeficiency virus. Journal of Virology 64, 5652-5.
2. AMEISEN, J. C. (1994). Programmed cell death (apoptosis) and AIDS pathogenesis. Acquired Immune Deficiency Syndrome Research and Human Retroviruses 10, 3-5.
3. BANDECCHI, P., MATTEUCCI, D., BALDINOTTI, F. et al. (1992). Prevalence of feline immunodeficiency virus and other retroviral infections in sick cats in Italy. Veterinary Immunology and Immunopathology 31, 337-45.
4. BARLOUGH, J. E., ACKLEY, C. D., GEORGE, J. W. et al. (1991). Acquired immune dysfunction in cats with experimentally induced feline immunodeficiency virus infection: comparison of short-term and long-term infections. Journal of the Acquired Immune Deficiency Syndrome 4, 219-27.
5. BEEBE, A. M., DUA, N., FAITH, T. G., MOORE, P. F., PEDERSEN, N. C. & DANDEKAR, S. (1994). Primary stage of feline immunodeficiency virus infection: viral dissemination and cellular targets. Journal of Virology 68, 3080-91.
6. BISHOP, S.A. (1995). Functional abnormalities in the human immune system of FIV-infected cats. In: Feline Immunology and Immunodeficiency. Eds.: Willett, B. J., Jarrett, O., New York: Oxford University Press. 150-69.
7. BISHOP, S. A., GRUFFYDD-JONES, T. J., HARBOUR, D. A. & STOKES, C. R. (1993). Programmed cell death (apoptosis) as a mechanism of cell death in peripheral blood mononuclear cells from cats infected with feline immunodeficiency virus (FIV). Clinical Experimental Immunology 93, 65-71.
8. BRALEY, J. (1994). FeLV and FIV: survey shows prevalence in the United States and Europe. Feline Practice 22, 25-8.
9. BROWN, E. W., YUHKI, N., PACKER, C. & O'BRIEN, S. J. (1994). Lion lentivirus related to feline immunodeficiency virus: epidemiologic and phylogenetic aspects. Journal of Virology 68, 5953-68.
10. BROWN, W. C., BISSEY, L., LOGAN, K. S., PEDERSEN, N. C., ELDER, J. H. & COLLISSON, E. W. (1991). Feline immunodeficiency virus infects both CD4+ and CD8+ T lymphocytes. Journal of Virology 65, 3359-64.
11. BROWN, W. C., OLMSTED, R. A., MARTENSON, J. S. & O'BRIEN, S. J. (1993). Exposure to FIV and FIPV in wild and captive cheetahs. Zoology and Biology 12, 135-42.
12. BROWN, P. J., HOPPER, C. D. & HARBOUR, D. A. (1991). Pathological features of lymphoid tissues in cats with natural feline immunodeficiency virus infection. Journal of Comparative Pathology 104, 345-55.
13. BRUNNER, D. & PEDERSEN, N. C. (1989). Infection of peritoneal macrophages in vitro and in vivo with feline immunodeficiency virus. Journal of Virology 63, 5483-8.
14. BURRACO, P., GUGLIELMINO, R., ABATE, O. et al. (1992). Large granular lymphoma in FIV-positive and FIV-negative cats. Journal of Small Animal Practice 33, 279-84.
15. CALLANAN, J.J. (1995). Feline immunodeficiency virus infection: a clinical and pathological perspective. In: Feline Immunology and Immunodeficiency. Eds.: Willett, B. J., Jarrett, O., Oxford New York: University Press. 111-30.
16. CALLANAN, J. J., HOSIE, M. J. & JARRETT, O. (1991). Transmission of feline immunodeficiency virus from mother to kitten. Veterinary Record 128, 332-3.
17. CALLANAN, J. J., MCGANDLISH, I. A. P., O'NEIL, B. et al. (1992). Lymphosarkoma in experimetally induced feline immunodefiency virus infection. Veterinary Record 130, 293-5.
18. CALLANAN, J. J., RACZ, P., THOMPSON, H. & JARRETT, O. (1993). Morphologic characterization of lymph node changes in feline immunodeficiency virus infection as an animal model of AIDS. In: Animal models of HIV and other retroviral infections. Basel: Karger. 115-36.
19. CHALMERS, S., SCHICK, R. O. & JEFFERS, J. (1989). Demodicosis in two cats seropositive for feline immunodeficiency virus. Journal of the American Veterinary Medical Association 194, 256-7.
20. CLEMENTS, J. E. & ZINK, M. C. (1996). Molecular biology and pathogenesis of animal lentivirus infections. Clinical Microbiology Reviews 9, 100-17.
21. CLERICI, M., STOCKS, N., ZAJAC, R. et al. (1989). Detection of three distinct patterns of T helper cell dysfunction in asymptomatic, human immunodeficiency virus-positive patients. Journal of Clinical Investigation 84, 1892-9.
22. COHEN, N. D., CARTER, C. N., THOMAS, M. A., LESTER, T. L. & EUGSTER, A. K. (1990). Epizootiologic association between feline immunodeficiency virus infection and feline leukemia virus seropositivity. Journal of the American Veterinary Association 197, 220-5.
23. COURCHAMP, F. & PONTIER, D. (1994). Feline immunodeficiency virus: an epidemiological review. Comptes rendus de l'Academie de Sciences Paris, Serie III. Sciences de la vie, 317, 1123-34.
24. COURCHAMP, F., PONTIER, D., LANGLAIS, M. & ARTOIS, M. (1995). Population dynamics of feline immunodeficiency virus within cat populations. Journal of Theoretical Biology 175, 553-60.
25. DANAVE, I. R., TIFFANY-CASTIGLIONI, E., ZENGER, E., BARHOUMI, R., BURGHARDT, R. C. & COLLISSON, E. W. (1994). Feline immunodefiency virus decreases cell-communication and mitochondrial membrane potential. Journal of Virology 68, 6745-50.
26. DANDEKAR, S., BEEBE, A. M., BARLOUGH, J. et al. (1992). Detection of feline immunodeficiency virus (FIV) nucleic acids in FIV-seronegative cats. Journal of Virology 66, 4040-9.
27. DAWSON, S., SMYTH, N. R., BENNET, M. et al. (1991). Effect of primary-stage feline immunodeficiency virus on subsequent feline calicivirus vaccination and challenge in cats. AIDS 5, 747-50.
28. DEAN, G. A., REUBEL, G. H., MOORE, P. F. & PEDERSEN, N. C. (1996). Proviral burden and infection kinetics of feline immunodeficiency virus in lymphocyte subsets of blood and lymph-node. Journal of Virology 70, 5165-9.
29. DELFIERRO, G. M., MEERS, J., THOMAS, J., CHADWICK, B., PARK, H. S. & ROBINSON, W. F. (1995). Quantification of lymphadenopathy in experimentally induced feline immunodeficiency virus infection in domestic cats. Veterinary Immunology and Immunopathology 46, 3-12.
30. DIEHL, L. J., MATHIASON-DUBARD, C. K., O'NIEL, L. L. & HOOVER, E. A. (1995). Longitudinal assessment of feline immunodeficiency virus kinetics in plasma by use of a quantitative competitive reverse transcriptase PCR. Journal of Virology 69, 2328-32.
31. DIETH, V., LUTZ, H., HAUSER, B. & OSSENI, P. (1989). Pathologische Befunde bei mit Lentiviren infizierten Katzen. Schweizer Archiv für Tierheilkunde 131, 19-25.
32. DOW, S. W., POSS, M. L. & HOOVER, E. A. (1990). Feline immunodeficiency virus: a neurotropic lentivirus. Journal of the Acquired Immune Deficiency Syndrome 3, 658-68.
33. DUA, N., REUBEL, G., HIGGINS, J. & PEDERSEN, N. C. (1994). The primary stage of experimentally-induced feline immunodeficiency virus infection: clinical, hematologic, and virologic features. Veterinary Immunology and Immunopathology 43, 337-55.
34. EGBERINK, H. F. (1991). FIV infection: an animal model for AIDS. Proefschrift ter verkrijging van de graad van doctor aan de Rijksuniversiteit te Utrecht.
35. EGBERINK, H. F., BORST, M., NIPHUIS, H. et al. (1990a). Suppression of feline immunodeficiency virus infection in vivo by 9-(2-phosphonomethoxyethyl) adenine. Proceedings of the National Academy of Science USA 87, 3087-91.
36. EGBERINK, H. F., EDERVEEN, J., MONTELARO, R. C., PEDERSEN, N. C., HORZINEK, M. C. & KOOLEN, M. J. M. (1990b). Intracellular proteins of feline immunodeficiency virus and their antigenic relationship with equine infectious anaemia virus proteins. Journal of General Virology 71, 739-43.
37. EGBERINK, H. F., HARTMANN, K. & HORZINEK, M. C. (1991a). Chemotherapy of feline immunodeficiency virus infection. Journal of the American Veterinary Medical Association 199, 1485-7.
38. EGBERINK, H. F., LUTZ, H. & HORZINEK, M. C. (1991b). Use of western blot and radioimmunoprecipitation for diagnosis of feline leukemia and feline immunodeficiency virus infections. Journal of the American Veterinary Medical Association 199, 1339-42.
39. EGBERINK, H. F., KELDERMANS, C. E. J. M., KOOLEN, M. J. M. & HORZINEK, M. C. (1992). Humoral immune response 10 feline immunodeficiency virus in cats with experimentally induced and naturally acquired infections. American Journal of Veterinary Research 53, 1133-8.
40. ELDER, J. H., SCHNÖLZER, M., HASSELKUS-LIGHT, C. S. et al. (1993). Identification of proteolytic processing sites within the gag and pol polyproteins of feline immunodefiency virus. Journal of Virology 67, 1869-76.
41. ENGLISH, R. V. & TOMPKINS, M. B. (1995). Effect of FIV infection on the peripheral immune system. In: Feline Immunology and Immunodeficiency. Eds: Willett, B. J., Jarrett, O., New York: Oxford University Press. 131-49.
42. ENGLISH, R. V., DAVIDSON, M. G., NASISSE, M. P., TOMKINS, W. A. & TOMKINS, M. B. (1990). Intraocular disease associated with feline immunodeficiency virus infection in cats. Journal of the American Veterinary Medical Association 196, 1116-9.
43. FERRER, L., RAMOS, J. A., BONAVIA, P., CABANES, J. & PUMAROLA, M. (1992). Cryptococcosis in two cats seropositive for feline immunodefiency virus. Veterinary Record 131, 393-4.
44. FLYNN, J. N., CANNON, C. A., LAWRENCE, C. E. & JARRETT, O. (1994). Polyclonal B-cell activation in cats infected with feline immunodeficiency virus. Immunology 81, 626-30.
45. FRATERNALI, M., ROSSI, L., SILVOTTI L., PIEDIMONTE, G. & MACNANI, M. (1994). Encapsulation of ddCTP in feline erythrocytes and inhibition of FIV infection. Advances in Bioscience 92, 59-66.
46. FRIEND, S. G., BIRCH, C. J., LORDING, P. M., MARSHALL, J. A. & STUDDERT, M. J. (1990). Feline immunodeficiency virus: prevalence, disease associations and isolation. Australian Veterinary Journal 67, 237-43.
47. FURUYA, T., KAWAGUCHI, Y., MIYAZAWA, T. et al. (1990). Existence of feline immunodeficiency virus infection in Japanese cat population since 1968. Japanese Journal of Veterinary Science 52, 891-3.
48. GEIER, S. A., KUFFER, M., HARTMANN, K. & GOEBEL, F. D. (1994). FIV-related retinal microangiopathy in cats infected with the feline immunodeficiency virus? [Abstr.] Joint European Researcher Meetings in Ophthalmology and Vision, Montpellier, Frankreich, 15-19 October 1994, 71.
49. GEORGE, J. W. & PEDERSEN, N. G. (1991). Hematologic and lymphocyte subset changes during the first 11 months of infection with FIV: a study of 61 cats [Abstr.]. First International Conference of Feline Immunodeficiency Virus Researchers, Davis, USA, 4-7 September 1991, 21.
50. GEORGE, J. W., PEDERSEN, N. C. & HIGGINS, J. (1993). The effect of age on the course of experimental feline immunodeficiency virus infection in cats. Acquired Immunodeficiency Syndrome Research and Human Retroviruses 9, 897-905.
51. GOFF, S. P. (1990). Retroviral reverse transcriptase: synthesis, structure, and function. Journal of the Acquired Immune Deficiency Syndrome 3, 817-31.
52. GOTHE, R., BEELITZ, P., SCHÖL, H. & BEER, B. (1992). Trichomonaden-Infektionen der Mundhöhle bei Katzen in Süddeutschland. Tierarztliche Praxis 20, 195-8.
53. GRANT, C.K. (1995). Immunoglobulin changes associated with feline immunodeficiency virus infection. In: Feline Immunology and Immunodeficiency. Eds: Willett, B. J., Jarrett, O., New York: Oxford University Press. 170-89.
54. GRINDEM, C. B., CORBETT, W. T., AMMERMAN, B. E. & TOMPKINS, M. T. (1989). Seroepidemiologic survey of feline immunodeficiency virus infection in cats of Wake County, North Carolina. Journal of the American Veterinary Medical Association 194, 226-8.
55. GRUFFYDD-JONES, T. J., HOPPER, C. D., HARBOUR, D. A. & LUTZ, H. (1989). Serological evidence of feline immunodeficiency virus infection in UK cats from 1975-76. Veterinary Record 123, 569-70.
56. GUSTINA, A. (1995). Molecular modeling of the structure of FIV protease. In: Aspartic Proteinases: Structure, Function, Biology, and Biomedical Implications. Eds.: Takahashi, K., New York: Plenum Press. 479-84.
57. HAASE, A. T. (1986). Pathogenesis of lentivirus infections. Nature 322, 30-6.
58. HARBOUR, D. A., WILLIAMS, P. D., GRUFFYDD-JONES, T. J., BURBRIDGE, J. & PEARSON, G. R. (1988). Isolation of a T-lymphotropic lentivirus from a persistently leukopenic domestic cat. Veterinary Record 122, 84-6.
59. HARDY, W. D. JR. & ZUCKERMANN, E. E. (1991). Comparison of ELISA, IFA and immunoblot tests for detection of feline immunodeficiency virus infection [Abstr.]. First World Congress of Feline Immunodeficiency Researchers, Davis, USA, 4-7 September 1991, 56.
60. HART, S. & NOLTE, I. (1993). Ergebnisse der Langzeitbehandlung spontan FIV-infizierter, kranker Katzen mit Zidovudin (Azidothymidin, AZT). Monatshefte-Veterinärmedizin 48, 223-31.
61. HART, S. & NOLTE, I. (1994). Hemostatic disorders in feline immunodeficiency virus-seropositive cats. Journal of Veterinary Internal Medicine 8, 355-62.
62. HARTMANN, K. (1995). Entwicklung eines Testsystems zur Erprobung neuer Medikamente gegen die FIV-Infektion der Katze als Modell für die Behandlung erworbener Immunschwächesyndrome. Habilitation med. vet., München.
63. HARTMANN, K. & HINZE, K. (1991). Epidemiologie und Klinik der FIV-Infektion in Bayern. Tierarztliche Praxis 19, 545-51.
64. HARTMANN, K. & LUTZ, H. (1989). Vorkommen von FIV-Infektionen im Einzugsbereich der Münchener Tierklinik. Tierärztliche Praxis 5, 81-3.
65. HARTMANN, K., DONATH, A., BEER, B. et al. (1992). Use of two virustatica (AZT, PMEA) in the treatment of FIV and of FeLV seropositive cats with clinical symptoms. Veterinary Immunology and Immunopathology 35, 167-75.
66. HARTMANN, K., BALZARINI, J., HIGGINS, J., DEÇLERCQ, E. & PEDERSEN, N. C. (1994a). In vitro activity of acyclic nucleoside phosphonate derivatives against feline immunodeficiency virus in Crandell Feline Kidney cells and feline blood lymphocytes. Antiviral Chemistry and Chemotherapy 5, 13-9.
67. HARTMANN, K., KUFFER, M., EGBERINK, H. F., LUTZ, H. & KRAFT, W. (1994b). Diagnostik der FIV-Infektion. Tierärztliche Praxis 22, 268-72.
68. HARTMANN, K., DONATH, A. & KRAFT, W. (1995a). AZT in the treatment of feline immunodeficiency virus infection. part 1. Feline Practice 5, 16-21.
69. HARTMANN, K., DONATH, A. & KRAFT, W. (1995b). AZT in the treatment of feline immunodeficiency virus infection. part 2. Feline Practice 6, 13-20.
70. HARTMANN, K., FERK, G., NORTH, T. W. & PEDERSEN, N. C. (1997). Attempts to cure early feline immunodeficiency virus infection with mega dose 9-[2R,5R-2,5-dihydro -5- phosphonomethoxy) -2-furanyl] adenine therapy: toxicity and efficacy. Antiviral Research (in press).
71. HASELTINE, W. A. (1991). Molecular biology of the human immunodeficiency virus type 1. PASEB Journal 5, 2349-60.
72. HAYES, K. A., LAFRADO, L. J., ERICKSON, J. G., MARK, J. M. & MATHES, L. E. (1993). Prophylactic ZDV therapy prevents early viremia and lymphocyte decline but not primary infection in feline immunodeficiency virus-inoculated cats. Journal of the Acquired Immunodeficiency Syndrome 6, 127-34.
73. HEIDEL, J. R., DUBEY, J. P., BLYTHE, L. L., WALKER, L. L., DUIMSTRA, J. R. & JORDAN, J. S. (1990). Myelitis in a cat infected with Toxoplasma gondii and feline immunodeficiency virus. Journal of the American Veterinary Medical Association 196, 316-8.
74. HEIDER, J. (1994). FIV-assoziierte Augenveranderungen der Katze [Abstr.]. 40. Jahrestagung Fachgruppe Kleintierkrankheiten der Deutschen Veterinärmedizinischen Gesellschaft, Dresden, Deutschland, 15-18 September 1994, 26.
75. HOLZNAGEL, E., HOFMANN-LEHMANN, R., ALLENSPACH, K., HUTTNER, S. & LUTZ, H. (1995). Die Bedeutung der in vitro-induzierten Lymphozyten-Apoptose bei Katzen mit einer experimentellen Felinen Immunschwäche Virus (FIV)-Infektion. 5. Jahrestagung der DVG, Fachgruppe Innere Medizin und Klinische Labordiagnostik, 2-5 March 1995.
76. HOPPER, C. D., SPARKES, A. H., GRUFFYDD-JONES, T. J. et al. (1989). Clinical and laboratory findings in cats infected with feline immunodeficiency virus. Veterinary Record 125, 341-6.
77. HOPPER, C. D., HARBOUR, D. & GRUFFYDD-JONES, T. J. (1992). Evidence of vertical transmission of FIV in experimentally and naturally infected cats [Abstr.]. European Commission Concerted Action on Feline AIDS Workshop, Lucca, Italy, 18-21 June 1992, 17.
78. HOSIE, M. J. (1995). The development of a vaccine against feline immunodeficiency virus. British Veterinary Journal 150, 25-39.
79. HOSIE, M. J. &: JARRETT, O. (1990). Serological responses of cats to feline immunodeficiency virus. AIDS 4, 263-78.
80. HOSIE, M. J., ROBERTSON, C. & JARRETT, O. (1989). Prevalence of feline leukaemia virus and antibodies to feline immunodeficiency virus in cats in the United Kingdom. Veterinary Record 128, 293-7.
81. HOSIE, M. J., SPARKES, A. & HOPPER, C. (1989). Feline immunodeficiency virus. In Practice 11, 87-95.
82. HURTREL, M., GANIERE, J.-P., GUELFI, J. F. et al. (1992). Comparison of early and late feline immunodeficiency virus encephalopathies. AIDS 6, 399-406.
83. HUTSON, C. A., RIDEOUT, B. A. & PEDERSEN, N. C. (1991). Neoplasia associated with feline immunodeficiency virus infection in cats of Southern California. Journal of the American Veterinary Medical Association 199, 1357-62.
84. ISHIDA, T., WASHIZU, T., TORIYABE, K., MOTOYOSHI, S. TOMODO, I. & PEDERSEN, N. C. (1989). Feline immunodeficiency virus infection in cats of Japan. Journal of the American Veterinary Medical Association 194, 221-5.
85. ISHIDA, T., TANIGUCHI, A., KONNO, A., WASHIZU, T. & TOMODO, I. (1990). Clinical and immunolgical staging of feline immunodeficiency virus (FIV) infection. In: Animal Models in AIDS. Eds.: Schellekens, H., Horzinek, M. C., Amsterdam: Elsevier. 189-99.
86. JARRETT, O., PACITTI, A. M., HOSIE, M. J. & REID, G. (1991). Comparison of diagnostic methods for feline leukemia virus and feline immunodeficiency virus. Journal of the American Veterinary Medical Association 199, 1362-4.
87. JORDAN, H. L., HOWARD, J., TOMPKINS, W. A. & KENNEDY-STOSKOPF, S. (1995). Detection of feline immunodeficiency virus in semen from seropositive domestic cats (Felis catus). Journal of Virology 69, 7328-33.
88. KAWAGUCHI, Y., MIYAZAWA, T., TOHYA, Y., TAKAHASHI, E. & MIKAMI, T. (1990). Quantification of feline immunodeficiency virus in a newly established feline T-lymphoblastoid cell line (MYA-1 cells). Archiv Virology 111, 269-73.
89. KIRSTENSEN, A. T., PETERSEN, S. F. & HOFF-JORGSEN, R. (1989). Feline AIDS (FAIDS) og feline immunodeficiency virus (FIV). Dansk Veterinar Tidsskript 72, 447-52.
90. KNOWLES, J. O., GASKELL, R. M., GASKELL, C. J., HARVEY, C. E. & LUTZ, H. (1989). Prevalence of feline calicivirus, feline leukaemia virus and antibodies to FIV in cats with chronic stomatitis. Veterinary Record 124, 336-8.
91. KÔLBL, S. & LUTZ, H. (1992). Die Infektion mit felinem Spumavirus (FeSFV): Häufigkeit bei Katzen in Österreich und Beziehung zur Infektion mit dem felinen Immunschwächevirus (FIV). Kleintierpraxis 37, 307-18.
92. KÔLBL, S. & SCHULLER, W. (1989). Serologische Untersuchungen zum Vorkommen des Felinen Immundefizienzvirus (FIV) bei Katzen in Österreich. Wiener Tierärztliche Monatsschrift 76, 185-9.
93. KOOLEN, M. & EGBERINK, H. F. (1990). Feline immunodeficiency virus (FIV): a model for antiviral chemotherapy. In: Animal models in AIDS. Eds.: Schellekens, H., Horzinek, M. C., Amsterdam: Elsevier. 185-8.
94. KUFFER, M. (1996). Vergleichende Untersuchung über die Wirksamkeit der Medikamente 9-(2-Phosphonylmethoxyethyl)adenin (PMEA) und 9-(3-Fluoro -2- phosphonylmethoxypropyl) adenin (FPMPA) bei natürlich FIV-infizierten Katzen. Dissertatio medicinae veterinariae, München.
95. LAPPIN, M. R., MARKS, A., GREEN, C. E. et al. (1993). Effect of feline immunodeficiency virus infection on toxoplasma gondii-specific humoral and cell-mediated immune responses of cats with serologic evidence of toxoplasmosis. Journal of Veterinary Internal Medicine 7, 95-100.
96. LAWRENCE, C. E., CALLANAN, B. J., WILLETT, B. J. & JARRETT, O. (1995). Cytokine production by cats infected with feline immunodeficiency virus: a longitudinal study. Immunology 85, 568-74.
97. LEHMANN, R., VONBEUST, B., NIEDERER, E. et al. (1992). Immunization-induced decrease of the CD4+ CD8+ ratio in cats experimentally infected with feline immunodeficiency virus. Veterinary Immunology and Immunopathology 35, 199-214.
98. LIN, D. S., BOWMANN, D. D. & JACOBSON, R. H. (1992). Immunological changes in cats with concurrent toxoplasma gondii and feline immunodefiency virus infections. Journal of Clinical Microbiology 30, 17-24.
99. LOMBARDI, S., GARZELLI, C., PISTELLO, M. et al. (1994). A neutralizing antibody-induced peptide of the V3 domaine og feline immunodeficiency virus envelope glycoprotein does not induce protective immunity. Journal of Virology 68, 8374-9.
100. LUTZ, H., EGBERINK, H., ARNOLD, P. et al. (1988). Felines T-lymphotropes Lentivirus (FTLV): Experimentelle Infektion und Vorkommen in einigen Ländern Europas. Kleintierpraxis 33, 445-92.
101. LUTZ, H., ISENBÜGEL, E., LEHMANN, R., SABAPARA, R. H. & WOLFENSBERGER, C. (1992). Retrovirus infections in non-domestic felides: serological studies and attempts to isolate a lentivirus. Veterinary Immunology and Immunopathology 35, 215-24.
102. MAGNANI, M., ROSSI, L., FRATERNALE, A. et al. (1994). Feline immunodeficiency virus infection of macrophages: in vitro and in vivo inhibition by dideoxycytidine-5′-triphosphate-loaded erythrocytes. AIDS Research and Human Retroviruses 19, 1179-86.
103. MAKI, N., MIYAZAWA, T., FUKASAWA, M. et al. (1992). Molecular characterization and heterogenity of feline immunodeficiency virus isolates. Archiv Virology 123, 29-45.
104. MANCIANTI, N., GIANNELLI, C., BENDINELLI, M. & POLI, A. (1992). Mycological findings in feline immunodeficiency virus-infected cats. Journal of Medical Veterinary Mycology 30, 257-9.
105. MATSUMURA, S., ISHIDA, T., WASHIZU, T. & TOMODA, I. (1994). Histopathology and viral antigen distribution in lymph nodes of cats naturally infected with feline immunodeficiency virus. Journal of Veterinary Medical Science USA 56, 523-8.
106. MEDLEAU, L. (1990). Recently described feline dermatoses. Veterinary Clinic of North America. Small Animal Practice 20, 1615-32.
107. MEERS, J., DELFIERRO, G. M., COPE, R. B., PARK, H. S., GREENE, W. K. & ROBINSON, W. F. (1993). Feline immunodeficiency virus infection: plasma but not peripheral blood mononuclear cell virus titer is influenced by zidovudine and cyclosporine. Archiv Virology 132, 67-81.
108. MIYAZAWA, T., FUKASAWA, M., HASEGAWA, A. et al. (1991). Molecular cloning of a novel isolate of feline immunodeficiency virus biologically and genetically different from the original US isolate. Journal of Virology 65, 1572-7.
109. MOENCH, T. R., WHALEY, K. J., MANDRELL, T. D., BISHOP, B. D. & WITT, C. J. (1993). The cat/feline immunodeficiency virus model for transmucosal transmission of AIDS: nonoxynol-9 contraceptive jelly blocks transmission by an infected cell inoculum. AIDS 7, 797-802.
110. MORAILLON, A. (1990). Feline immunodepressive retrovirus infections in France. Veterinary Record 126, 68-9.
111. NORTH, T. W., CRONN, R. C., REMINGTON, K. M., TANDBERG, R. T. & JUDD, R. C. (1990). Characterization of reverse transcriptase from feline immunodeficiency virus. Journal of Biological Chemistry 265, 5121-8.
112. NEU, H., MOENNIG, V., LEIDINGER, K. & BUSSIAN, E. (1989). Erste Ergebnisse über die Verbreitung FIV- (FTLV-) seropositiver Katzen in Deutschland und Interpretation der Ergebnisse. Der praktische Tierarzt 3, 38-40.
113. O'CONNOR, T. P. JR., TANGUAY, S., STEINMAN, R. et al. (1989). Development and evaluation of immunoassay for detection of antibodies to the feline T-lymphotropic lentivirus (feline immunodeficiency virus). Journal of Clinical Microbiology 27, 474-9.
114. O'DAIR, H. A., HOPPER, C. D., GRUFFYDD-JONES, T. J., HARBOUR, D. A. & WATERS, L. (1994). Clinical aspects of Chlamydia psittaci infection in cats infected with feline immunodeficiency virus. Veterinary Record 134, 365-8.
115. O'NEIL, S. A., BURKHARD, M. J. & HOOVER, E. A. (1996). Frequent perinatal transmission of feline immunodeficiency virus by chronically infected cats. Journal of Virology 70, 2894-901.
116. O'NEIL, S. A., LAPPIN, M. R., REIF, J. S., MARKS, A. & GREENE, C. E. (1991). Clinical and epidemiological aspects of feline immunodeficiency virus and Toxoplasma gondii coinfections in cats. Journal of the American Animal Hospital Association 27, 211-20.
117. OHNO, K., OKAMOTO, Y., MIYAZAWA, T. et al. (1994). Induction of apoptosis in a T lymphoblastoid cell line infected with feline immunodeficiency virus. Archiv Virology 135, 153-8.
118. OLMSTED, R. A., BARNES, A. K., YAMAMOTO, J. K., HIRSCH, V. M., PURCELL, R. H. & JOHNSON, P. R. (1989a). Molecular cloning of feline immunodeficiency virus. Proceedings of the National Academy of Science USA 86, 2448-52.
119. OLMSTED, R. A., HIRSCH, V. M., PURCELL, R. H. & JOHNSON, P. R. (1989b). Nucleotide sequence analysis of feline immunodeficiency virus: genome organization and relationship to other lentiviruses. Proceedings of the National Academy of Science USA 86, 8088-92.
120. OLMSTED, R. A., LANGLEY, R., ROELKE, M. E. et al. (1992). Worldwide prevalence of lentivirus infection in wild feline species: epidemiologic and phylogenetic aspects. Journal of Virology 66, 6008-18.
121. PARODI, A. L., FEMENIA, F., MORAILLON, A., CRESPEAU, F. & FONTAINE, J. J. (1994). Histopathological changes in lymph nodes of cats experimentally infected with the feline immunodeficiency virus. Journal of Comparative Pathology 111, 165-74.
122. PEDERSEN, N. C. & BARLOUGH, J. E. (1991). Clinical overview of feline immunodeficiency virus. Journal of the American Veterinary Medical Association 199, 1298-305.
123. PEDERSEN, N. C., HO, E. W., BROWN, M. L. & YAMAMOTO, J. K. (1987). Isolation of a T-lymphotropic virus from domestic cats with an immunodeficiency-like syndrome. Science 235, 790-3.
124. PEDERSEN, N. C., YAMAMOTO, J. K., ISHIDA, T. & HANSEN, H. (1989). Feline immunodeficiency virus infection. Veterinary Immunology and Immunopathology 21, 111-29.
125. PEDERSEN, N. C. & TORTEN, M. (1995). A review of feline immunodeficiency virus infection. Israel Journal of Veterinary Medicine 50, 5-13.
126. PEDERSEN, N. C., TORTEN, M., RIDEOUT, B. et al. (1990). Feline leukemia virus infection as a potentiating cofactor for the primary and secondary stages of experimentally induced feline immunodeficiency virus infection. Journal of Virology 64, 598-606.
127. PHILLIPS, T. R., PROSPERO-GARCIA, O., PUAOI, D. L. et al. (1994). Neurological abnormalities associated with feline immunodeficiency virus infection. Journal of General Virology 75, 979-87.
128. PHILPOTT, M. S., EBNER, J. P. & HOOVER, E. A. (1992). Evaluation of 9-(2-phosphonylmethoxyethyl)adenine therapy for feline immunodeficiency virus using quantitative polymerase chain reaction. Veterinary Immunology and Immunopathology 35, 155-66.
129. PODELL, M., OGLESBEE, M., MATHES, L., KRAKOWKA, S., OLMSTED, R. A. & LAFRADO, L. (1993). AIDS-associated encephalopathy with experimental feline immunodeficiency virus infection. Journal of Acquired Immune Deficiency Syndrome 6, 758-71.
130. POLI, A., ABRAMO, F., TACCINI, E. et al. (1993). Renal involvement in feline immunodeficiency virus infection: a clinicopathological study. Nephron 64, 282-8.
131. RAMOS-VARA, J. A., FERRER, L. & VISA, J. (1994). Pathological findings in a cat with cryptococcosis and feline immunodeficiency virus infection. Histology and Histopathology 9, 305-8.
132. REID, G., RIGBY, M. A., MCDONALD, M., HOSIE, M. J., NEIL, J. C. & JARRETT, O. (1991). Immunodiagnosis of feline immunodeficiency virus infection using recombinant viral p17 and p24. AIDS 5, 1477-83.
133. REID, R. W., BARR, M. C. & SCOTT, F. W. (1992). Retrospective serological survey for the presence of feline immunodeficiency virus antibody: a comparison of ELSA and IFA techniques. Cornell Veterinary 82, 359-69.
134. REINACHER, M. (1990). Pathology of FIV-infection. Schweizer Archiv für Tierheilkunde 132, 461-2.
135. REINACHER, M. & FRESE, K. (1991). Untersuchungen zur Glomerulonephritis bei Hund und Katze. Tierärztliche Praxis 19, 175-80.
136. REINACHER, M. & HOLZNAGEL, E. (1991). Post mortem diagnosis of spontaneous FIV infection [Abstr.]. First World Congress of Feline Immunodeficiency Researchers, Davis, USA, 4-7 September 1991, 2.
137. REMINGTON, K. M., CHESEBRO, B., WEHRLY, K., PEDERSEN, N. C. & NORTH, T. W. (1991). Mutants of feline immunodeficiency virus resistant to 3′-Azido-3′-Deoxythymidine. Journal of Virology 65, 308-12.
138. REUBEL, G. H., DEAN, G. A., GEORGE, J. W., BARLOUGH, J. E. & PEDERSEN, N. C. (1994). Effects of incidental infections and immune activation on disease progression in experimentally feline immunodeficiency virus-infected cats. Journal of the Acquired Immune Deficiency Syndrome 7, 1013-5.
139. RIDEOUT, B. A., LOWENSTINE, L. J., HUTSON, C. A., MOORE, P. F. & PEDERSEN, N. C. (1992). Characterization of morphologic changes and lymphocyte subset distribution in lymph nodes from cats with naturally acquired feline immunodeficiency virus infection. Veterinary Pathology 29, 391-9.
140. RIMMELZWAAN, G. F., SIEBELINK, K. H. J., BROOS, H. et al. (1994). Gag- and env-specific antibodies in cats after natural and experimental infection with feline immunodeficiency virus. Veterinary Microbiology 39, 153-65.
141. ROBINSON, W. F., SHAW, S. E., ALEXANDER, R. & ROBERTSON, J. (1990). Feline immunodeficiency virus. Australian Veterinary Journal 67, 278-80.
142. RODGERS, S. J. & BALDWIN, C. A. (1990). A serologic survey of Oklahoma cats for antibodies to feline immunodeficiency virus, coronavirus, toxoplasma gondii and for antigen to feline leukemia virus. Journal of Veterinary Diagnostic Investigation 2, 180-3.
143. SABINE, M., MICHELSEN, J., THOMAS, F. & ZHENG, M. (1988). Feline AIDS. Australian Veterinary Practice 18, 105-7.
144. SELLOON, R. K., JORDAN, H. L., KENNEDY-STOSKOPF, S., TOMPKINS, M. B. & TOMPKINS, W. F. (1994). Feline immunodeficiency virus can be experimentally transmitted via milk during acute maternal infection. Journal of Virology 68, 3380-5.
145. SHELTON, G. H., MCKIM, K. D., COOLEY, P. L., DICE, P. F., RUSSEL, R. G. & GRANT, C. K. (1989). Feline leukemia virus and feline immunodeficiency virus infection in a cat with lymphoma. Journal of the American Veterinary Medical Association 194, 249-52.
146. SHELTON, G. H., WALTIER, R. M., CONNOR, S. G. & GRANT, G. K. (1989). Prevalence of feline immunodeficiency virus and feline leukemia virus infections in pet cats. Journal of the American Veterinary Medical Association 25, 7-12.
147. SHELTON, G. H., GRANT, G. K., COTTER, S. M., GARDNER, M. B., HARDY, W. D. JR. & GIACOMO, R. F. D. L. (1990). Feline immunodeficiency virus and feline leukemia virus infections and their relationships to lymphoid malignancies in cats: a retrospective study (1968-1988). Journal of the Acquired Immune Deficiency Syndrome 3, 623-30.
148. SHELTON, G. H., LINENBERGER, M. L. & ABKOWITZ, J. L. (1991). Hematologic abnormalities in cats seropositive for feline immunodeficiency virus. Journal of the American Veterinary Medical Association 199, 1353-7.
149. SIEBELINK, K. H. J., HUISMAN, W., KARLAS, J. A., RIMMEL ZWAAN, G. F., BOSCH, M. L. & OSTERHAUS, A. D. M. E. (1995). Neutralization of feline immunodeficiency virus by polyclonal feline antibody: simultaneous involvement of hypervariable regions 4 and 5 of the surface glycoprotein. Journal of Virology 69, 5124-7.
150. SMITH, J. L., ALLEN, S. J. W. & CHERRINGTON, J. M. (1995). A rapid antiviral in situ enzyme-linked immunosor bent assay for feline immunodeficiency virus. Journal of Virological Methods 54, 29-38.
151. SMYTH, N. R., BENNETT, M., GASKELL, R. M., MCCRACKEN, C. M., HART, C. A. & HOWE, J. L. (1994a). Effect of 3′-acido-2′,3′-dideoxythymidine (AZT) on experimental feline immunodeficiency virus infection in domestic cats. Research in Veterinary Science 57, 220-4.
152. SMYTH, N. R., MCCRACKEN, C., GASKELL, R. M., CAMERON, J. M., COATES, J. A. V., GASKELL, C. J., HART, C. A. & BENNETT, M. (1994b). Susceptibility to cell culture of feline immunodeficiency virus to eighteen antiviral agents. Journal of Antimicrobial Chemotherapy 34, 589-94.
153. SPARKES, A. H., HOPPER, C. D., MILLARD, W. G., GRUFFYDD-JONES, T. J. & HARBOUR, D. A. (1993). Feline immunodeficiency virus infection clinicopathologic findings in 90 naturally occuring cases. Journal of Veterinary Internal Medicine 7, 85-90.
154. STEINMAN, R., DOMBROWSKI, J., O'CONNOR, T. et al. (1990). Biochemical and immunological characterization of the major structural proteins of feline immunodeficiency virus. Journal of General Virology 71, 701-6.
155. SWINNEY, G. R., PAULI, J. V., JONES, B. R. & WILKS, C. R. (1989). Feline T-lymphotropic virus (FTLV) (feline immunodeficiency virus) in cats in New Zealand. New Zealand Veterinary Journal 37, 41-3.
156. TALBOTT, R. L., SPARGER, E. E., LOVELACE, K. M. et al. (1989). Nucleotide sequence and genomic organization of feline immunodeficiency virus. Proceedings of the National Academy of Science USA 86, 5743-7.
157. TANABE-TOCHIKURA, A., TOCHIKURA, T. S., BLAKESLEE, J. R., OLSEN, R. G. & MATHES, L. E. (1992). Anti-human immunodeficiency virus (HIV) agents are also potent and selective inhibitors of feline immunodeficiency virus
158. TENORIO, A. P., FRANTI, C. E., MADEWELL, B. R. & PEDERSEN, N. C. (1991). Chronic oral infections of cats and their relationship to persistent oral carriage of feline calici-, immunodeficiency, or leukemia viruses. Veterinary Immunology and Immunopathology 29, 1-14.
159. TERRY, A., CALLANAN, J. J., FULTON, R., JARRETT, O. & NEIL, J. (1995). Molecular analysis of tumours from feline immunodeficiency (FIV)-infected cats: an indirect role for FIV? International Journal of Cancer 61, 227-32.
160. THOMAS, J. B., ROBINSON, W. F., CHADWICK, B. J., ROBERTSON, I. D. & JONES, P. S. (1993). Leukogram and biochemical abnormalities in naturally occurring feline immunodeficiency virus infection. Journal of the American Animal Hospital Association 29, 272-8.
161. TORTEN, M., FRANCHINI, M., BARLOUGH, J. E. et al. (1991). Progressive immune dysfunction in cats experimentally infected with feline immunodeficiency virus. Journal of Virology 65, 2225-30.
162. UELAND, K. L. & LUTZ, H. (1992). Prevalence of feline leukemia virus and antibodies to feline immunodeficiency virus in cats in Norway. Zentralblatt Veterinärmedizin (B) 39, 53-8.
163. VAHLENKAMP, T., DERONDE, A., BALZARINI, J. et al. (1995). (R) -9- (2-Phosphonylmethoxypropyl) -2,6-diaminopurine is a potent inhibitor of feline immuno deficiency virus infection. Antimicrobial Agents and Chemotherapy 39, 746-9.
164. VAHLENKAMP, T., TIMMERMANS, I., DERONDE, A., HORZINEK, M.C. & EGBERINK, H.F. (1996). Macrophage tropism of FIV: sequences of the surface envelope protein involved [Abstr.]. 3. International Symposium Feline Retrovirus Research, Fort Collins, Colorado, USA, 6-9 March 1996, 11.
165. VERSCHOOR, E. J., BOVEN, L. A., BLAAK, H., VANVLIET, A. L.W., HORZINEK, M. C. & DERONDE, A. (1995). A single mutation within the V3 envelope neutralization domain of feline immunodeficiency virus determines its tropism for CrFK cells. Journal of Virology 69, 4752-7.
166. WALKER, C., MALIK, R. & CANFIELD, P. J. (1995). Analysis of leucocytes and lymphocyte subsets in cats with naturally-occurring cryptococcosis but differing feline immunodeficiency virus status. Australian Veterinary Journal 72, 93-7.
167. WASMOEN, T., ARMIGER-LUHMAN, S., EGAN, C. et al. (1992). Transmission of feline immunodeficiency virus from infected queens to kittens. Veterinary Immunology and Immunopathology 35, 83-93.
168. WATERS, L., HOPPER, C. D., GRUFFYDD-JONES, T. J. & HARBOUR, D. A. (1993). Chronic gingivitis in a colony of cats infected with feline immunodeficiency virus and feline calicivirus. Veterinary Record 132, 340-2.
169. WEIMER, R., SCHWEIGHOFFER, T., SCHIMPF, K. & OPELZ, G. (1989). Helper and suppressor T-cell function in HIV-infected hemophilia patients. Blood 74, 298-302.
170. WHEELER, D. W., MITCHELL, T. W., GASPER, P. W., BARR, M. C. & WHALEN, L. R. (1991). FIV infection associated with neurologic abnormalities [Abstr.]. First International Conference of Feline Immunodeficiency Virus Researchers, Davis, USA, 4-7 September 1991, 31.
171. WILHELM, N. (1996). Vergleichende Untersuchung zum therapeutischen Einsatz von (R)-9-(2-Phosphonylmethoxypropyl)-2,6-diaminopurin (PMPDAP) und Melittin bei natürlich FIV-infizierten Katzen. Dissertatio medicinae veterinariae, München.
172. WILLETT, B. J., HOSIE, M. J., JARRETT, O. & NEIL, J. N. (1994). Identification of a putative cellular receptor for feline immunodeficiency virus as the feline homolgue of CD9. Immunology 81, 228-33.
173. WILLETT, B. J., FLYNN, N. & HOSIE, J. M. (1997). FIV infection of the domestic cat: an animal model for AIDS. Immunology Today 18, 182-9.
174. WITT, C. J., MOENCH, T. R., GITTELSOHN, A. M., BISHOP, B. D. & CHILDS, J. E. (1989). Epidemiologic observations on feline immunodeficiency virus and toxoplasma gondii coinfection in cats in Baltimore, MD. Journal of the American Veterinary Medical Association 194, 229-33.
175. YAMAMOTO, J. K., SPARGER, E., HO, E. W. et al. (1988). Pathogenesis of experimentally induced feline immunodeficiency virus infection in cats. American Journal of Veterinary Research 49, 1246-58.
176. YAMAMOTO, J. K., HANSEN, H., HO, E. W. et al. (1989). Epidemiologic and clinical aspects of feline immunodeficiency virus infection in cats from the continental United States and Canada and possible mode of transmission. Journal of the American Veterinary Medical Association 194, 213-20.
177. ZENGER, E., BROWN, W. C., SONG, W. et al. (1993). Evaluation of cofactor effect of feline syncytium-forming virus on feline immunodeficiency virus infection. American Journal of Veterinary Research 54, 713-8.
178. ZETNER, K., KAMPFER, P., LUTZ, H. & HARVEY, C. (1989). Vergleichende immunologische und virologische Untersuchungen von Katzen mit chronischen oralen Erkrankungen. Wiener Tierärztliche Monatsschrift 76, 303-8.